NIFTY 50▲24,213.30
217.95 (0.91%)
SENSEX▲79,476.63
694.39 (0.88%)
NIFTY BANK▲52,207.25
992.00 (1.94%)
TATA MOTORS▲835.65
11.55 (1.40%)
SUZLON ENERGY▲67.37
1.05 (1.58%)
TATA STEEL▲152.29
5.34 (3.63%)
INDIAN RAILWAY FINANCE CORP▼151.44
-1.80 (-1.17%)
TATA POWER▲434.10
5.05 (1.18%)
RAIL VIKAS NIGAM▲450.90
4.70 (1.05%)
RELIANCE INDUSTRIES▲1,305.30
3.15 (0.24%)
VODAFONE IDEA▲8.14
0.26 (3.30%)
ZOMATO▼241.87
-3.21 (-1.31%)
RELIANCE POWER▼41.52
-0.51 (-1.21%)
INDIAN RENEWABLE ENERGY▼204.77
-0.61 (-0.30%)
ADANI POWER▲603.45
18.45 (3.15%)
YES BANK▲20.62
0.29 (1.43%)
STATE BANK OF INDIA▲849.20
19.35 (2.33%)
NHPC▼80.18
-3.12 (-3.75%)
HDFC BANK▲1,757.85
43.75 (2.55%)
OLA ELECTRIC MOBILITY LTD▼74.18
-6.66 (-8.24%)
JIO FIN SERVICES LTD▲321.90
2.05 (0.64%)
INDIAN OIL CORP▲140.80
1.87 (1.35%)
BHARAT ELECTRONICS▲286.35
2.20 (0.77%)
GTL INFRA▲2.20
0.09 (4.27%)
MRF▼1,19,530.15
-1346.60 (-1.11%)
ADANI PORT & SEZ▼1,329.35
-19.90 (-1.47%)
JAIPRAKASH POWER VENTURES▲17.96
0.08 (0.45%)
ITC▼480.20
-4.40 (-0.91%)
- GENNEX LABORATORIES LTD
GENNEX LABORATORIES LTD Share Price
GENNEX
₹20.60+₹0.19 (0.93%) TodayLast updated on 05 Nov, 2024 | 15:51 IST
GENNEX LABORATORIES LTD Share Price Chart
Please wait...
Company overview
GENNEX LABORATORIES LTD Financials
Market cap  ₹464 Crs | Open ₹20.01 | Close ₹20.41 |
Circuit range ₹21.43 - ₹19.39 | Day range ₹20.01 - ₹21.00 | Year range ₹11.45 - ₹29.00 |
Volume 6,07,823 | Avg. traded ₹20.64 | Revenue (12m) ₹99 Crs |
GENNEX LABORATORIES LTDGennex Laboratories Limited is an India-based active pharmaceutical ingredient manufacturing company. The Company is engaged in the business of manufacturing bulk drugs, intermediaries, and biotech products. The Company has a robust product portfolio spread over product segments encompassing Expectorants, Muscle Relaxants, Analgesic and Anti-Fungal. The Company operates through the Pharmaceutical Products (Bulk Drugs) segment. The Company's products include active pharmaceutical ingredients, such as Guaifenesin USP/BP/EP/IP, which is an expectorant, (mucolyte); Methocarbamol USP/IP, which is a relaxant (skeletal muscle relaxant); Phenazopyridine Hcl USP, which is an urinary tract analgesic; Fluconazole EP/BP/USP/IP, which is an anti-fungal product; Mephenesin IP/BP, which is a muscle relaxant; Sertraline Hcl, which is a selective serotonin reuptake inhibitors (SSRIS), and others. The Company has manufacturing facilities in India which cater to both domestic and international markets.
GENNEX LABORATORIES LTD Key indicators
52 week high ₹29.00 | 52 week low ₹11.45 | P/E ratio 27.57 |
P/B ratio 2.68 | ROE 7.43% | ROCE 10.7% |
Dividend yield -- | Debt/Equity ratio 0.03 | EPS 0.26 |
Learn more
Featured in
Investment checklist: (3/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
GENNEX LABORATORIES LTD Fundamentals
GENNEX LABORATORIES LTD Financial Ratios
Operating profit margin11.19% | Net profit margin6.39% |
ROE7.43% | ROA5.55% |
ROCE10.7% |
Learn more
GENNEX LABORATORIES LTD Share Price history
| Day | Open | Close | Change % |
|---|---|---|---|
Mon, Nov 4 2024 | ₹21.18 | ₹20.41 | -3.64% |
Fri, Nov 1 2024 | ₹21.05 | ₹21.18 | |
Thu, Oct 31 2024 | ₹20.59 | ₹20.60 | |
Wed, Oct 30 2024 | ₹20.20 | ₹20.19 | |
Tue, Oct 29 2024 | ₹20.20 | ₹19.92 | -1.04% |
Mon, Oct 28 2024 | ₹20.25 | ₹20.13 | -1.90% |
Fri, Oct 25 2024 | ₹21.00 | ₹20.52 | -5.00% |
Thu, Oct 24 2024 | ₹22.00 | ₹21.60 | -0.69% |
GENNEX LABORATORIES LTD Shareholding Pattern
Promoters (18.42%) | Mutual Funds (0%) | Retail and other (81.58%) |
Foreign institutions-FII (0%) | Other domestic institutions (0%) |
Retail and other
Learn more
Events
Corporate actions
Rights Issue • 1:2
Ex date 21 Jul 2022
Learn more
More
Stocks Similar to GENNEX LABORATORIES LTD
People also bought